Navigation Links
Combining liver cancer treatments doubles survival rates, UVA researchers find
Date:4/15/2008

liver cancer and has significant mortality and mortality. Of the approximately 2,000 cases diagnosed each year, the vast majority of patients survive up to three months without intervention or four to six months with decompression treatment.

Stents alone do not destroy or shrink the tumors or cancer cells. We were not surprised that the combined therapy offers a significant benefit to the patient, as this is accepted treatment in Europe, said Kahaleh. However the FDA (Food and Drug Administration) wants to see more data so we have completed what we believe is the first published comparative American study on the treatment.

Kahaleh hopes to begin a multi-center trial within six months.


'/>"/>

Contact: David Foreman
daf4n@virginia.edu
434-924-2242
University of Virginia Health System
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Combining Internet With Office Visits Cut Heart Attack Risks
2. NeoStrata Clinical Findings Reveal Benefits of Combining Glycolic Acid Peels and Targeted Home Care With Microdermabrasion for Optimized Treatment of Photodamaged Skin
3. Combining Medications Often Best Strategy to Battle Rheumatoid Arthritis
4. In blood vessel stents, innovative materials allow better control, delivery of gene therapy
5. New Treatments Help Fight Liver, Colon Cancer
6. Health Care Work Force Too Small, Unprepared for Aging Baby Boomers; Higher Pay, More Training, and Changes in Care Delivery Needed to Avert Crisis
7. Penn researchers find targeted therapy combination overcomes treatment resistance in liver cancer
8. New technique in treating patients with liver cancer proves effective
9. Mayo Clinic identifies treatment target for liver cancer recurrence and survival
10. New York Cigarette Tax Increase Delivers Victory for Kids and Taxpayers
11. Two Liver Cancer Treatments Better Than One
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/9/2008)...- OxyBand Technologies, Inc. today,announced that ...my to,evaluate the company,s patented cutting edge...r military wounds. OxyBand Technologies has develo...e oxygen gas into wounds for,faster healing. The O...to,accelerate healing and, in laboratory testing, ...
(Date:5/9/2008)...y Flights en Route, NEW YORK, May 9 /PRNewswire-U... emergency supplies landed in Yangon today, carryi... more planeloads containing,medicines, emergency h...ren, are planned over the next three days., "The ... can make a,difference in the life of a Myanmar ch...
(Date:5/9/2008)...e of European nightlife, study says , , ...oung adults in Europe are drinking alcohol and tak...ey of more than 1,300 people who are regular night...of males and a quarter of females aged 16 to 35 dr...e cocaine, ecstasy and cannabis are used to enhanc...
(Date:5/9/2008)...he artery-opening devices , , FRIDAY, Ma...rstone of heart-disease treatment, tiny tools that...y maintaining the flow of blood through their arte...d following artery-clearing angioplasty procedures...upply of blood to the heart and throughout the bod...
Breaking Medicine News(10 mins):Health News:OxyBand Technologies Signs Army Contract 2Health News:UNICEF: 'Every Second Can Make a Difference' to Myanmar's Children; 20% Already Suffering from Diarrhea, Malaria reported 2Health News:UNICEF: 'Every Second Can Make a Difference' to Myanmar's Children; 20% Already Suffering from Diarrhea, Malaria reported 3Health News:Young Adults Using Alcohol, Drugs for Better Sex 2Health News:Drug-Coated Stents Still Spark Debate 2Health News:Drug-Coated Stents Still Spark Debate 3
...ickness or Human African trypanosomiasis is caused...se-tse fly//, which passes on the parasite called ... There has been a come-back of this disease over t...rld Health Organization (WHO) has tried to collect...
...ith cancer have almost a 80% chance of winning a b...ren who were diagnosed for cancer 20 to 30 years a...braving odds and coming out of cancer, this does n...erm health problems in adulthood. One of the co-...
...hnic medicine experts are calling for protection o...arted by a lack of standards and new practitioners...icines at the South Central University for Nationa...5 minority groups, accounting for up to seven perc...
... virus appears to be fast engulfing Uttar Pradesh'...riday. "Of the 31 dengue-positive cases admitted t...ffected districts,// 20 were from Lucknow alone," ...f the state health department, told IANS. He said...
Other Medicine News:Health News:Understanding Sleeping Sickness 2Health News:Understanding Sleeping Sickness 3Health News:Childhood Cancer Survivors May Suffer Health Problems in Adulthood 2Health News:Chinese Experts Call for Protection of Traditional Medicines 2
(Date:5/9/2008)... 9 /PRNewswire-USNewswire/ -- Osteoarthritis is a,...t affects almost 50,million people in the United S...in bone joints. The novel investigational pain med...sic, provided significant relief,for patients with...h,placebo, and with fewer gastrointestinal side ef...
(Date:5/9/2008)...9 /- Ardea Biosciences, Inc...very and development of,small- molecule therapeuti...ry diseases, including gout, today announced that ...ent, Finance and Operations and Chief,Financial Of...our board of,directors shortly thereafter. The Com...
(Date:5/8/2008)...8 /- DATATRAK International... company focused on global,eClinical solutions for...operating results for the first quarter of 2008., ...e decreased,approximately 41% to $2,088,000 and th...$(0.16) per share on both a basic and diluted basi...
(Date:5/8/2008)... data support potential of asenapine in the treatm...I disorder, WASHINGTON, May 8 /PRNewswire-FirstCa...oday announced that an overview of asenapine clini...at the 161st Annual Meeting of the,American Psychi...ta from,the studies, involving patients with bipol...
Breaking Medicine Technology:Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 2Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 3Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 4Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 5Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 2Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 3Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 4Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 5Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 6DATATRAK International Reports First Quarter Results for 2008 2DATATRAK International Reports First Quarter Results for 2008 3DATATRAK International Reports First Quarter Results for 2008 4DATATRAK International Reports First Quarter Results for 2008 5DATATRAK International Reports First Quarter Results for 2008 6DATATRAK International Reports First Quarter Results for 2008 7Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 2Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 3Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 4Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 5Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 6Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 7Scientists say tropics are next emerging disease hotspot 14320 1Scientists say tropics are next emerging disease hotspot 14320 2Scientists say tropics are next emerging disease hotspot 14320 3Leventhal Weight Loss President Featured on Cover of Young Lawyer 14317 1Leventhal Weight Loss President Featured on Cover of Young Lawyer 14317 2Healthcare Tech and the World 3A Personalized Technology to Benefit Healthcare Consumers in the Future 14315 1Healthcare Tech and the World 3A Personalized Technology to Benefit Healthcare Consumers in the Future 14315 2Healthcare Tech and the World 3A Personalized Technology to Benefit Healthcare Consumers in the Future 14315 3South African Hospital Uses Packard Childrens as Model for Nurse Retention 14312 1South African Hospital Uses Packard Childrens as Model for Nurse Retention 14312 2South African Hospital Uses Packard Childrens as Model for Nurse Retention 14312 3
...ntercell AG (VSE,“ICLL”) has been inf...c. on the results of a Phase I study involving,in ...safety and,immunogenicity of different doses of th...ccus aureus vaccine is based on a conserved protei...Identification,Program (AIP®) and was licensed...
...apy significantly,increases patients_ overall surv...udy published,yesterday in the Journal of Clinical...(MCP*) was shown to significantly improve,survival...d to,chemotherapy alone.1 Follicular lymphoma is t...rogressing but incurable form of,lymphoma. , The s...
Other Medicine Technology:Staphylococcus aureus vaccine development on track ? safe and,immunogenic in Phase I clinicaltrials 2Staphylococcus aureus vaccine development on track ? safe and,immunogenic in Phase I clinicaltrials 3Innovative Cancer Drug MabThera Again Shown To Improve Survival,Rates In Patients With Lymphoma 2Innovative Cancer Drug MabThera Again Shown To Improve Survival,Rates In Patients With Lymphoma 3Innovative Cancer Drug MabThera Again Shown To Improve Survival,Rates In Patients With Lymphoma 4
The ImagingPlanet 55 mm surgical microscope video adapter: superior optical quality and precise engineering make this 55mm focal length adapter an excellent decision for use with your Leica surgical
The ImagingPlanet 70 mm Surgical Microscope Adapter. Superior optical quality and precise engineering make this 70 mm focal length adapter an excellent decision for use with your Leica surgical micr
The Optronics MicroFire - Monochrome: An easy to use 2-Megapixel Monochrome microscope camera with Firewire connectivity. MicroFire - Monochrome provides high-efficiency imaging beyond 900nm. The cam
...chnologically advanced Micro-dermabrasion machine ... research, it offers the therapist safety, and com...xibility in skin exfoliation. It is superior to tr... are biologically respected. Through regular stimu...
Medicine Products: